ArticleJMIR research protocols2024

Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.

Phyu Sin Aye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.